[Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites]

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Context:

• Persistent ventricular tachycardia/fibrillation poses a significant risk of sudden cardiac death (SCD) within the first year post-resuscitation.
• Traditional anti-arrhythmic agents offer limited improvement in prognosis for these high-risk patients.
• Implantable cardioverter-defibrillators (ICDs) effectively terminate life-threatening arrhythmias, improving care for patients at high risk of SCD.

Purpose:

• To discuss the indication catalogue for implantable cardioverter-defibrillator (ICD) implantation based on a guideline paper.
• To evaluate the current evidence regarding the impact of ICDs on overall mortality in patients resuscitated from ventricular arrhythmias.
• To highlight the challenges in establishing long-term recommendations due to evolving technology and limited data.

Summary:

• ICDs reduce the annual risk of sudden cardiac death (SCD) to 1-2% in selected patient groups.
• The impact of ICDs on overall mortality, particularly in patients with preserved left ventricular function, requires further substantiation.
• Accurate patient selection for ICD therapy necessitates comprehensive cardiological diagnostics and specialized centers.

Impact:

• ICDs represent a significant advancement in managing patients at high risk of sudden cardiac death.
• Further research is crucial to definitively establish the benefits of ICDs on overall survival.
• The findings underscore the need for expert evaluation and management in specialized cardiological centers for optimal patient outcomes.